期刊文献+

维持性血液透析患者代谢综合征发病情况及危险因素分析 被引量:4

Analysis on risk factors for metabolic syndrome in patients with maintaining hemodialysis
原文传递
导出
摘要 目的 探讨维持性血液透析患者代谢综合征(metabolic syndrome,MS)发病情况及影响因素.方法 于2010年6月至12月将北京朝阳医院血液净化中心规律透析的162例尿毒症患者分为MS组(66例)和非代谢综合征(NMS)组(96例),比较两组人体测量学指标、生化指标的差异,应用二项logistic回归分析探求MS发生的危险因素.结果 MS发生率为40.7%(66/162).MS组与NMS组体重指数[(24.2±3.1)比(21.6±2.7)kg/m2]、腰围[(93±8)比(79±7)cm]、白细胞[(6.8±1.5)×10^9/L比(5.6±1.4)×10^9/L]、超敏C反应蛋白[(7±5)比(4±3)mg/L]、高密度脂蛋白胆固醇[(0.99±0.26)比(1.39±0.39)mmol/L]、低密度脂蛋白胆固醇[(2.5±0.8)比(2.1±0.7)mmol/L]、甘油三酯[(2.1±1.1)比(1.3±0.8)mmol/L]、血糖[(5.9±2.7)比(4.8±1.3)mmol/L]、血清铁[(16±7)比(13±5)μmol/L]、尿酸[(429±114)比(388±88)μmol/L]、二氧化碳结合力[(22±4)比(23±4)mmol/L]比较,差异均有统计学意义(均P〈0.05).但两组非血管通路侧肱三头肌皮下脂肪厚度、主观综合性营养评估法评分比较差异无统计学意义(均P〉0.05).二项logistic回归分析显示血清铁(OR=1.058,95%CI=1.001~1.119)、白细胞(OR=1.786,95%CI=1.346~2.371)、超敏C反应蛋白(OR=1.101,95%CI=1.010~1.201)是MS发生的独立危险因素.结论 维持性血液透析患者伴发MS发生率高,微炎症可能参与了MS发生,血清铁、白细胞、超敏C反应蛋白是MS发生的独立危险因素;维持性血液透析患者营养状况与MS无必然联系. Objective To investigate prevalence of metabolic syndrome (MS) and its related factors in patients with maintaining hemodialysis (MHD). Methods A total of 162 cases on MHD in Beijing Chaoyang Hospital during June to December 2010, were enrolled in this study and divided into MS group and non-MS group according to the diagnostic criteria for MS set by the International Diabetes Federation. Anthropometric and blood biochemical characteristics of the two groups were compared with t-test and x2 test Risk factors for MS were explored with binary logistic regression analysis. Results Prevalence of MS was 40. 7% (66/162) . There was significant difference found in body mass index [(24. 2 ±3. 1) vs. (21. 6 ±2. 7) kg/m2], waistline circumference[(93 ±8) vs. (79 ±7)cm] , white blood cell count [(6. 8 ± 1. 5) × 10^9/L vs. (5. 6 ± 1. 4) × 10^9/L] , hypersensitive serum C-reactive protein [(7 ± 5)vs. (4 ±3) mg/L], high-density lipoprotein-cholesterol [(0. 99 ±0. 26)vs. (1.39 ±0.39) mmol/L], low-density lipoprotein-cholesterol [(2. 5 ± 0. 8) vs. ( 2. 1 ± 0. 7) mmol/L], triglyceride ( TG) [( 2. 1 ±1.1 )vs. (1.3±0.8) mmol/L], fasting blood glucose [(5.9±2. 7)vs. (4.8±1.3) mmol/L], serum level of iron [(16±7)vs. (13 ±5) μmol/L], uric acid [(429±114) vs. (388±88) (μmol/L], and carbon dioxide combining power (CO2CP) [(22 ±4)vs. (23 ±4) mmol/L]between MS group and non-MS group (All P 〈 0.05 ) . But there was no significant difference found in subjective global assessment of nutritional status (SGA) , thickness of skin fold of the triceps muscle (TSF) between the two groups (Both P 〉 0.05). Binary logistic regressive analysis revealed that serum level of iron (OR = 1.058,95% CI = 1.001 -1. 119), white blood cell count ( OR = 1. 786,95% CI = 1. 346 - 2.371) and hypersensitive serum C-reactive protein (OR = 1. 101,95% CI = 1.010 - 1.201 ) were independent risk factors for MS in MHD patients. Conclusions Morbidity of MS is high in patients with MHD, involved with inflammation process. Serum level of iron, white blood cell count and hypersensitive serum C-reactive protein are independent risk factors for MS in patients with MHD and no inevitable connection between MS and nutritional status in them is found.
出处 《中华全科医师杂志》 2011年第8期543-547,共5页 Chinese Journal of General Practitioners
关键词 肾透析 代谢综合征X 危险因素 炎症 Renal dialysis Metabolic syndrome X Risk factor Inflammation
  • 相关文献

参考文献19

  • 1Eckel RH,Crundy SM,Zimmet PZ.The metabolic syndrome.Lancet,2005,365:1415-1428.
  • 2Executive summary.United States renal data system 1999 annual data report Am J Kidney Dis,1999,34:S9-S19.
  • 3Detsky AS,McLaughlin JR,Baker JP,et al.What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr,1987,11:8-13.
  • 4Segura J,Campo C,Roldan C,et al.Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances.J Am Soc Nephrol,2004,15 Suppl 1:S37-42.
  • 5Gu D,Reynolds K,Wu X,et al.Prevalence of the metabolic syndrome and overweight among adults in China.Lancet,2005,365:1398-1405.
  • 6Young DO,Lund RJ,Haynatzki G,et al.Prevalence of the metabolic syndrome in an incident dialysis population.Hemodial Int,2007,11:86-95.
  • 7Lee SW,Park GH,Lee SW,et al.Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients.Nephrol Dial Transplant,2007,22:2554-2562.
  • 8Tsangalis G,Papaconstantinou S,Kosmadakis G,et al.Prevalence of the metabolic syndrome in hemodialysis.Int J Artif Organs,2007,30:118-123.
  • 9Frohlich M,Imhof A,Berg G,et al.Association between Creactive protein and features of the metabolic syndrome:a population-based study.Diabetes Care,2000,23:1835-1839.
  • 10Jofre R,Rodriguez-Benitez P,Lopez-Gomez JM,et al.Inflammatory syndrome in patients on hemodialysis.J Am Soc Nephrol,2006,17:S274-280.

同被引文献41

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 2ZelaznickaM, Kocelak P, Olszanecka GM, et al. Cinacalcet ther-apy and cardiovascular risk in hemodialysis patients [ J ]. Postepy HigMed Dosw (Online),2012,66:722 - 729.
  • 3郭磊.联机血液透析滤过治疗尿毒症并发急性左心衰15例[J].海南医学,2007,18(11):114-115. 被引量:1
  • 4Roberson LL, Aneni EC, Maziak W, et al. Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all -cause mortality--a systematic review [J]. BMC Public Health, 2014.14 : 14.
  • 5Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China [J]. Lancet, 2005, 365(16) : 1398-1405.
  • 6Young Do, Lund R J, Haynatzki G, et al. Prevalence of the metabolic syndrome in an indident dialysis population [J]. Hemodial Int, 2007, 11 ( 1 ) : 86-95.
  • 7Sarmad Said, German T, Hernandez. The link between chronic kidney disease and cardiovascular disease [J]. J Nephropathol, 2014, 3(3) :99-104.
  • 8Femandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion [J]. Clin Chem, 2005, 51(7): 1201-1205.
  • 9Lee HJ, Jang HB, Park JE, et al. Relationship between serum levels of body iron parameters and insulin resistance and metabolic syndrome in Koren children [J]. Osong Public Health Res Perspect, 2014, 5(4): 204-210.
  • 10Turk U, Akbulut M, Yildiz A, et al. Comparative effect of oral pulse and intravenbous calcitriol treatment in hemodialysis patients: the effect on serum ILl and IL6 and bone mineraldensity [J]. Nefro, 2002, 90(2) : 188-194.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部